Evidence map›Paper›PMID 34610287›Full record

ArticleNeuropharmacology2021

Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons.

Yijuan Du, You Bin Lee, Steven M Graves

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yijuan DuDepartment of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA.
You Bin LeeDepartment of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA.
Steven M GravesDepartment of Pharmacology, University of Minnesota, Minneapolis, MN, 55455, USA. Electronic address: gravess@umn.edu.
University of Minnesota · US

Funding

Viral Innovation CoreP30DA048742 · NIDA · UNIVERSITY OF MINNESOTA · PI TIMOTHY J EBNER · 2020 to 2026
$19.0M
Chronic alcohol-induced mitochondrial oxidant stress and Alzheimer's related pathogenesisR01AG070962 · NIA · UNIVERSITY OF MINNESOTA · PI GRAVES, STEVEN MICHAEL · 2020 to 2024
$1.9M
Methamphetamine, mitochondria, and neurodegenerationR01DA051450 · NIDA · UNIVERSITY OF MINNESOTA · PI GRAVES, STEVEN MICHAEL · 2021 to 2025
$1.9M
Methamphetamine and Parkinson's disease: converging mechanisms of pathogenesisR00DA039253 · NIDA · UNIVERSITY OF MINNESOTA · PI GRAVES, STEVEN MICHAEL · 2018 to 2020
$747k
Methamphetamine and Parkinson's disease: converging mechanisms of pathogenesisK99DA039253 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GRAVES, STEVEN MICHAEL · 2016 to 2017
$274k
NIA NIH HHS R01 AG070962NIDA NIH HHS K99 DA039253NIDA NIH HHS P30 DA048742NIDA NIH HHS R00 DA039253NIDA NIH HHS R01 DA051450
6 · The paper itself

Abstract

Methamphetamine (meth) increases monoamine oxidase (MAO)-dependent mitochondrial stress in substantia nigra pars compacta (SNc) axons; chronic administration produces SNc degeneration that is prevented by MAO inhibition suggesting that MAO-dependent axonal mitochondrial stress is a causal factor. To test whether meth similarly increases mitochondrial stress in ventral tegmental area (VTA) axons, we used a genetically encoded redox biosensor to assess mitochondrial stress ex vivo. Meth increased MAO-dependent mitochondrial stress in both SNc and VTA axons. However, despite having the same meth-induced stress as SNc neurons, VTA neurons were resistant to chronic meth-induced degeneration indicating that meth-induced MAO-dependent mitochondrial stress in axons was necessary but not sufficient for degeneration. To determine whether L-type Ca

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAnimalsAntioxidantsCalcium Channels, L-TypeDopaminergic NeuronsMaleMethamphetamineMiceMitochondriaMonoamine Oxidase InhibitorsNeurodegenerative DiseasesPars CompactaVentral Tegmental Area3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAntioxidantsCalcium Channels, L-TypeMethamphetamineMonoamine Oxidase InhibitorsL-type Ca(2+) channelMethamphetamineMitochondrial stressMonoamine oxidaseNeurodegenerationSubstantia nigra pars compactaVentral tegmental area

Identifiers

PMID34610287
PMCPMC8556701
OpenAlexW3203691870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.